BD intensifies syringe output to meet U.S. demand amid China quality concerns

BD’s North Canaan plant has increased its output of syringes by more than 40% to meet the needs of U.S. healthcare customers after the FDA launched an ongoing investigation into quality issues with plastic syringes made in China.
Provided








Melissa Gamwell, crafting custom Valentine’s Day cards in her office in Cornwall. Kevin Greenberg



Detail of“Specimen 42” by Catherine Latson at KBFAD.H. Callahan
Provided




